Company intelligence / Profile preview

AirAvant Medical

Deerfield Beach, Florida, United States

Ownership: Private
Employees: ~11
Development stage: Other

Overview

Bongo Rx, AirAvant Medical's lead product, is FDA-cleared and clinically proven to treat mild to moderate obstructive sleep apnea and snoring without the need for powered CPAP machines; it provides a portable, non-surgical alternative with demonstrated efficacy in clinical testing and broad availability for U.S. veterans via VA partnership.

Therapeutic areas: Pulmonology
Modalities: Expiratory Positive Airway Pressure (EPAP) Device
Industry: Therapeutic Medical Devices

Partnerships

First Nation Group (distribution for U.S. Veterans Affairs and military)

Beyond the preview

Go deeper on AirAvant Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AirAvant Medical.

Explore the full profile